白术芍药散在溃疡性结肠炎治疗中的应用效果综述
Review on the Application Effect of Baizhu Shaoyao Powder in the Treatment of Ulcerative Colitis
摘要: 白术芍药散是治疗止痛止泻著名方剂，近年来被广泛应用于溃疡性结肠炎的治疗中，且疗效显著。众多研究从临床、基础等视角分析了其对溃疡性结肠炎治疗的具体机制。国内外研究关于白术芍药散治疗溃疡性结肠炎药理作用机制均有系统描述，并对探讨该方治疗疡性结肠炎的作用机制奠定基础。本文通过查找最近几年的相关文献，分别从溃疡性结肠炎发病机制、白术芍药散对溃疡性结肠炎免疫调节、修复肠黏膜屏障、调抗氧化应激等方面进行综述，以期为后期研究提供新的参考路径。
Abstract: Baizhu Shaoyao Powder is a famous prescription for the treatment of pain and diarrhea, which has been widely used in the treatment of ulcerative colitis in recent years, and the effect is remarkable. Many studies have analyzed the specific mechanism of its treatment of ulcerative colitis from clinical and basic perspectives. The pharmacological mechanism of Baizhu Shaoyao Powder in the treatment of ulcerative colitis has been systematically described in domestic and foreign studies, and has laid a foundation for exploring the mechanism of action of this prescription in the treatment of selective colitis. By searching relevant literature in recent years, this paper reviewed the pathogenesis of ulcerative colitis, the immune regulation of Baizhu Shaoyao Powder in ulcerative colitis, the repair of intestinal mucosal barrier, and the regulation of antioxidant stress, in order to provide a new reference path for later research.
文章引用：江泳楠, 谭雪春, 苏云飞, 韦艳艳, 陈远能. 白术芍药散在溃疡性结肠炎治疗中的应用效果综述[J]. 中医学, 2025, 14(3): 1107-1115. https://doi.org/10.12677/tcm.2025.143167

参考文献

[1] 冯文林, 伍海涛, 谭海波. 痛泻要方对肠道疾病多靶点治疗作用的研究[J]. 西部中医药, 2020, 33(8): 166-168.
[2] 刘平. 白术芍药散联合美沙拉嗪肠溶片治疗溃疡性结肠炎的临床疗效分析[J]. 中国肛肠病杂志, 2020, 40(8): 31-32.
[3] 何钦, 周思源, 牛淑睿, 等. 白术芍药散主要成分治疗炎性肠病作用机制的网络药理学研究[J]. 中国药师, 2022, 25(2): 258-263.
[4] 温玉军, 李玉萍, 林兵. 探讨白术芍药散治疗溃疡性结肠炎的临床疗效[J]. 世界最新医学信息文摘, 2018, 18(39): 166-167.
[5] 徐洋洋. 白术芍药散炮制前后化学成分的变化及与溃疡性结肠炎疗效的相关性研究[D]: [硕士学位论文]. 南京: 南京中医药大学, 2018.
[6] Xu, Y.Y., Cai, H., Duan, Y., et al. (2017) [Research Progress of Baizhu Shaoyao Powder in Treating Ulcerative Colitis]. China Journal of Chinese Materia Medica, 42, 856-862.
[7] Meyer, M., Grabherr, F., Hadjihannas, M.V., Schwärzler, J., Mayr, L., Jukic, A., et al. (2025) P0143 Isotretinoin Treatment Protects against Crohn’s Disease Development and Suppresses Pro-Inflammatory Cytokines That Drive Experimental Enteritis. Journal of Crohn’s and Colitis, 19, i533-i533. [Google Scholar] [CrossRef] 
[8] Abd El-Dayem, G., Rasheed, N., Ghanem, R., Albadrani, G., Abdel-Daim, M. and Abdel-Latif, M. (2023) Essential Oils and Organic Acid Blends Potentially Enhance Growth and Ameliorate Enteritis and Inflammatory Response after Challenge with Clostridium Perfringens in Chickens. Damanhour Journal of Veterinary Sciences, 10, 19-27. [Google Scholar] [CrossRef] 
[9] 张家豪, 王建波, 薛亚楠, 等. 基于miRNA-29c/白血病抑制因子轴探讨针刺调节脾虚大鼠肠道炎症机制研究[J]. 中华中医药学刊, 2024, 42(5): 98-102.
[10] 袁翠, 雷晓红, 莫黎. 基于p38MARK/MMP-9信号通路探讨自拟复方愈溃汤对UC大鼠肠道炎症, 氧化应激及屏障功能的影响[J]. 医学综述, 2023, 29(14): 2891-2896.
[11] 许博洋, 杨雯迪, 李伟, 等. 中西医治疗溃疡性结肠炎的比较与分析[J]. 中华全科医学, 2024, 22(10): 1640-1644, 1713.
[12] 耿白璐, 郭静, 胡晓飞, 等. CD3+HLA-DR+活化T淋巴细胞对溃疡性结肠炎患者疾病严重程度和药物疗效的预测价值[J]. 胃肠病学和肝病学杂志, 2023, 32(2): 146-150.
[13] Dorofeyev, A.E., Dorofeyeva, A.A., Kiriyan, E.A., Rassokhina, O.A. and Dynia, Y.Z. (2020) Genetic Polymorphism in Patients with Early and Late Onset of Ulcerative Colitis. Wiadomości Lekarskie, 73, 87-90. [Google Scholar] [CrossRef] 
[14] Pérez-Jeldres, T., Tyler, C.J., Boyer, J.D., Karuppuchamy, T., Bamias, G., Dulai, P.S., et al. (2018) Cell Trafficking Interference in Inflammatory Bowel Disease: Therapeutic Interventions Based on Basic Pathogenesis Concepts. Inflammatory Bowel Diseases, 25, 270-282. [Google Scholar] [CrossRef] [PubMed]
[15] Venkateswaran, S., Prince, J., Cutler, D.J., Marigorta, U.M., Okou, D.T., Prahalad, S., et al. (2018) Enhanced Contribution of HLA in Pediatric Onset Ulcerative Colitis. Inflammatory Bowel Diseases, 24, 829-838. [Google Scholar] [CrossRef] [PubMed]
[16] El Hadad, J., Schreiner, P., Vavricka, S.R. and Greuter, T. (2023) The Genetics of Inflammatory Bowel Disease. Molecular Diagnosis & Therapy, 28, 27-35. [Google Scholar] [CrossRef] [PubMed]
[17] 沈照峰. 基于真实世界的中医药治疗溃疡性结肠炎的临床应用研究和网状meta分析[D]: [硕士学位论文]. 南京: 南京医科大学, 2020.
[18] 王伟欢, 代玉玺, 吴卫东, 等. 中等强度持续运动与高强度间歇运动对高脂膳食大鼠肠道炎症及α7型烟碱乙酰胆碱受体, 核转录因子κΒ p65的影响[J]. 中华物理医学与康复杂志, 2024, 46(12): 1072-1078.
[19] 王梓宇, 张智慧, 吴鹏, 等. 基于肠道菌群和短链脂肪酸代谢探讨甘草制远志降低肠道炎症的作用机制[J]. 中草药, 2023, 54(14): 4556-4563.
[20] 王潇璐, 姚海强, 万瑾毅. 中药-肠道菌群互作效应在溃疡性结肠炎治疗中的作用[J]. 世界中医药, 2023, 18(1): 132-136.
[21] 纪周新, 贺德. 粪肠球菌脂磷壁酸激活Toll样受体2抑制胰腺导管癌BxPC-3细胞的增殖、侵袭和迁移[J]. 中国肿瘤生物治疗杂志, 2021, 28(5): 477-481.
[22] 王奇桢, 于海霞, 李杰, 等. 短小芽孢杆菌SE5肽聚糖和脂磷壁酸联合添加对斜带石斑鱼免疫, 抗氧化和肠道形态的影响[J]. 饲料研究, 2024, 47(21): 62-66.
[23] 陈伟坚, 姜涛, 周宜, 等. LC-MS联合单细胞测序分析探讨参苓白术散治疗原发性骨质疏松症的作用机制[J]. 中国骨质疏松杂志, 2023, 29(10): 1458-1465.
[24] 刘妍琪, 李雪莹, 张虹冰玉, 等. 脑肠同调治疗常见慢性病的中药药性及证-症-方-药网络研究[J]. 北京中医药, 2023, 42(1): 93-97.
[25] Magnusson, M.K., Brynjólfsson, S.F., Dige, A., et al. (2016) Macrophage and Dendritic Cell Subsets in IBD: ALDH+ Cells Are Reduced in Colon Tissue of Patients with Ulcerative Colitis Regardless of Inflammation. Mucosal Immunology, 9, 171-182.
[26] Ninomiya, K., Hisabe, T., Okado, Y., Takada, Y., Yamaoka, R., Sato, Y., et al. (2018) Comparison of Small Bowel Lesions Using Capsule Endoscopy in Ulcerative Colitis and Crohn’s Disease: A Single-Center Retrospective Analysis. Digestion, 98, 119-126. [Google Scholar] [CrossRef] [PubMed]
[27] 厉启芳, 刘善军, 景德怀, 等. 基于临床疗效及Th1/Th2、Th17/Treg炎性平衡变化探讨痛泻要方治疗溃疡性结肠炎的机制g[J]. 辽宁中医杂志, 2018, 45(8): 1569-1572.
[28] Tian, L., Li, Y., Zhang, J., Chang, R., Li, J. and Huo, L. (2018) IL-9 Promotes the Pathogenesis of Ulcerative Colitis through STAT3/SOCS3 Signaling. Bioscience Reports, 38, BSR20181521. [Google Scholar] [CrossRef] [PubMed]
[29] 朱向东, 李兰珍, 段永强, 等. 痛泻要方对溃疡性结肠炎大鼠结肠组织病理形态及血清中相关因子含量的影响[J]. 中国中医药信息杂志, 2013, 20(4): 41-43.
[30] 朱亚珍, 厉启芳, 李鹤, 等. 痛泻要方对肝郁脾虚型溃疡性结肠炎大鼠炎性因子表达量的影响[J]. 时珍国医国药, 2018, 29(5): 1053-1057.
[31] 杨淼, 胡菁华. 缺血性结肠炎患者56例临床观察[J]. 中国现代药物应用, 2018, 12(16): 125-127.
[32] 刘琦, 罗霞, 罗爽, 等. 芍药苷通过抑制NLRP3炎症小体治疗溃疡性结肠炎小鼠的研究[J]. 中药新药与临床药理, 2018, 29(4): 409-414.
[33] 刘峰, 刘林, 王垂杰. 溃疡性结肠炎病因病机及治疗进展[J]. 山东中医药大学学报, 2021, 45(1): 143-147.
[34] 徐阳丽, 苏莎莎. 炎症性肠病患者血清生物化学指标, 血常规及凝血功能变化的临床意义[J]. 临床医学进展, 2024, 14(5): 661-668.
[35] 李婷, 朱向东, 杨意, 等. 痛泻要方对溃疡性结肠炎大鼠下丘脑中IL-6, IL-6R表达的影响[J]. 中国实验方剂学杂志, 2017, 23(11): 103-108.
[36] 杨意, 朱向东, 翟艳会, 等. 痛泻要方对肝郁脾虚型溃疡性结肠炎大鼠结肠组织中gp130、SOCS3表达的影响[J]. 山东医药, 2017, 57(34): 20-23.
[37] Villapol, S. (2017) Roles of Peroxisome Proliferator-Activated Receptor Gamma on Brain and Peripheral Inflammation. Cellular and Molecular Neurobiology, 38, 121-132. [Google Scholar] [CrossRef] [PubMed]
[38] 郭军雄, 马丽, 汪斌, 等. 基于“痛泻要方”探讨防风对tnbs诱导大鼠UC结肠TLR-4及外周血中TNF-α、IL-1β的影响[J]. 中医药学报, 2018, 46(1): 58-61.
[39] Banerjee, S., Biehl, A., Gadina, M., Hasni, S. and Schwartz, D.M. (2017) JAK-STAT Signaling as a Target for Inflammatory and Autoimmune Diseases: Current and Future Prospects. Drugs, 77, 521-546. [Google Scholar] [CrossRef] [PubMed]
[40] 刘苗, 申睿, 朱向东, 等. 痛泻要方对肝郁脾虚型溃疡性结肠炎模型大鼠 TNF-α、Casepase3、Chop 的影响[J]. 中医学报, 2019, 34(7): 1436-1441.
[41] 俞媛, 王卿华, 陈媛洁, 等. 痛泻要方对溃疡性结肠炎患者免疫功能及肠道黏膜屏障的调节作用[J]. 中国中西医结合消化杂志, 2020, 28(11): 858-862.
[42] Gao, W., Wang, C., Yu, L., Sheng, T., Wu, Z., Wang, X., et al. (2019) Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway. BioMed Research International, 2019, Article ID: 6769789. [Google Scholar] [CrossRef] [PubMed]
[43] 杨倩倩, 周建波, 蔡升, 等. 白术芍药散联合美沙拉嗪治疗溃疡性结肠炎临床疗效及对血清和结肠黏膜NGAL、MMP-9表达水平的影响[J]. 浙江中西医结合杂志, 2018, 28(12): 1011-1014.
[44] 陈畅. 三个对“氧化应激”的重新认识[J]. 生物化学与生物物理进展, 2024, 51(10): 2292-2297.
[45] 汪四海, 方朝晖, 马格非, 等. 基于炎症反应、氧化应激和细胞凋亡研究中药防治糖尿病心肌病的机制进展[J]. 中国临床保健杂志, 2023, 26(6): 854-860.
[46] 张婷, 施敏, 廖陈敏, 等. 痛泻要方治疗溃疡性结肠炎的作用机制研究进展[J]. 世界中医药, 2021, 16(10): 1643-1648.
[47] 王小嘉, 张玉峰, 李辽飞. 痛泻要方治疗消化系统疾病机制及临床应用研究进展[J]. 国际中医中药杂志, 2024, 46(5): 673-677.
[48] Zhang, Z., Zhang, M., Hong, J., Guo, C., Jiang, X., Dong, P., et al. (2025) Tryptophan Ameliorates Soybean Meal-Induced Enteritis via Remission of Oxidative Stress, Mitophagy Hyperactivation, and Apoptosis Inhibition in Hybrid Yellow Catfish Gut (Pelteobagrus fulvidraco ♀ × Pelteobagrus vachelli ♂). Aquaculture, 596, Article ID: 741851. [Google Scholar] [CrossRef] 
[49] Zhao, Z., Dong, Y., Jiang, X., Wang, J., Qin, W., Liu, Z., et al. (2024) Five Commonly Used Traditional Chinese Medicine Formulas in the Treatment of Ulcerative Colitis: A Network Meta-Analysis. World Journal of Clinical Cases, 12, 5067-5082. [Google Scholar] [CrossRef] [PubMed]
[50] Zhang, B., Su, X., Xie, Z., et al. (2020) Inositol-Requiring Kinase 1Regulates Apoptosis via Inducing Endoplasmic Reticulum Stress in Colitis Epithelial Cells. Digestive Diseases and Sciences, 66, 3015-3025.
[51] 何芳, 丁敏, 甄海宁, 等. 基于NF-κB通路研究芍药苷对LPS诱导支气管上皮细胞炎症反应的作用及机制研究[J]. 中国免疫学杂志, 2024, 40(7): 1387-1391.
[52] 刘昊源, 李彦杰, 秦合伟, 等. 基于网络药理学探讨五参顺脉汤对动脉粥样硬化AopE-/-小鼠的作用机制[J]. 中国畜牧兽医, 2023, 50(1): 377-389.
[53] 杨文, 宋纯东, 陈晨晨, 等. 基于NF-κB/COX-2炎症通路探讨益气养阴活血方对糖尿病肾病大鼠肾脏保护作用机制[J]. 中医药学报, 2023, 51(4): 21-26.
[54] 薛明明, 薛锋, 康毅敏, 等. 环氧化酶抑制剂对高血压心肌肥厚的影响及机制的研究[J]. 中国科技成果, 2021, 22(9): 49-51.
[55] Lu, P. and Zhao, Y. (2020) Targeting NF-κB Pathway for Treating Ulcerative Colitis: Comprehensive Regulatory Characteristics of Chinese Medicines. Chinese Medicine, 15, Article No. 15. [Google Scholar] [CrossRef] [PubMed]
[56] 张超贤, 郭李柯, 郭晓凤. 环氧合酶-2-1195G/A和锰超氧化物歧化酶9Ala /Val基因多态性与高脂饮食的交互作用及其与溃疡性结肠炎的关系[J]. 中国医学科学院学报, 2015, 37(1): 37-43.
[57] 吴昊, 于小红, 王焕君, 等. 雷公藤对右旋葡聚糖硫酸钠诱导的溃疡性结肠炎小鼠肠道菌群的影响[J]. 中草药, 2020, 51(2): 387-396.
[58] Shama, J., Garcia-Medina, R., Pouysségur, J. and Vial, E. (2008) Major Contribution of MEK1 to the Activation of ERK1/ERK2 and to the Growth of LS174T Colon Carcinoma Cells. Biochemical and Biophysical Research Communications, 372, 845-849. [Google Scholar] [CrossRef] [PubMed]
[59] 崔树婷, 刘喜平, 崔国宁, 等. 参苓白术散与痛泻要方对溃疡性结肠炎大鼠BMSCs向结肠黏膜组织归巢作用的影响[J]. 中成药, 2020, 42(2): 480-484.
[60] 陈嘉慧, 刘喜平, 崔国宁, 等. 参苓白术散和痛泻要方对溃疡性结肠炎大鼠外周血来源BMSCs黏附及迁移特性干预作用的比较研究[J]. 时珍国医国药, 2019, 30(9): 2068-2071.